Cardiac Markers Clash For Hospital, Lab Space: Biosite Triages R&D Projects

Biosite's pursuit of additional disease markers for its Triage immunoassay meter will continue unabated this summer, even as the company defends BNP test market share from newcomer Abbott Labs and imminent rival Dade Behring

More from Archive

More from Medtech Insight